IA
PTLA

IFP Advisors’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

IFP Advisors’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-3,786
Closed -$52.7K – 3054
2020
Q1 		$27K Buy
3,786
+136
+4% +$1.7K ﹤0.01% 1382
2019
Q4 		$89K Sell
3,650
-72
-2% -$1.99K 0.01% 1006
2019
Q3 		$101K Buy
+3,722
New +$104K 0.01% 1056
2019
Q1 		– Sell
-100
Closed -$2K – 3768
2018
Q4 		$2K Hold
100
– – ﹤0.01% 3236
2018
Q3 		$3K Sell
100
-27
-21% -$882 ﹤0.01% 3482
2018
Q2 		$5K Sell
127
-3,073
-96% -$118K ﹤0.01% 3314
2018
Q1 		$156K Hold
3,200
– – 0.01% 1111
2017
Q4 		$156K Hold
3,200
– – 0.01% 1118
2017
Q3 		$173K Buy
3,200
+830
+35% +$48.7K 0.01% 1230
2017
Q2 		$133K Buy
2,370
+170
+8% +$6.81K 0.01% 1373
2017
Q1 		$86K Sell
2,200
-4,205
-66% -$134K ﹤0.01% 1587
2016
Q4 		$144K Buy
6,405
+2,100
+49% +$41K 0.01% 1223
2016
Q3 		$98K Sell
4,305
-13
-0.3% -$305 0.01% 1376
2016
Q2 		$102K Buy
+4,318
New +$107K 0.01% 1329
2016
Q1 		– Sell
-2,247
Closed -$116K – 3758
2015
Q4 		$116K Buy
+2,247
New +$109K 0.01% 1100

Other funds holding PTLA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

IFP Advisors's PTLA Position: Q2 2020 in Review

IFP Advisors sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q2 2020, closing a stake of 3,786 shares — an estimated $52.7K sold.

IFP Advisors first reported a position in PTLA in Q4 2015 and held it in 15 quarters. The position peaked at $173K in Q3 2017. 162 funds tracked by Wall St. Rank hold PTLA as of Q2 2020.

  • IFP Advisors reported no remaining Portola Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
  • IFP Advisors sold 3,786 Portola Pharmaceuticals, Inc. shares in Q2 2020, an estimated $52.7K.
  • IFP Advisors first reported a position in Portola Pharmaceuticals, Inc. in Q4 2015 and held it in 15 quarters.
  • IFP Advisors's Portola Pharmaceuticals, Inc. position peaked at $173K in Q3 2017.
  • 162 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2020.

Based on IFP Advisors's 13F filing for Q2 2020, filed 5 Aug 2020.